tirzepatide direct to consumer Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity UPDATE [March 7, 2025]: OFA

A compelling area for future research is to investigate whether GLP-1-RAs modulate taste perception in part by altering the expression or signaling of leptin or cholecystokinin (CCK) in taste bud cells, creating an integrated hormonal milieu that fine-tunes taste sensitivity based on energy status

(Clinical Principle) Guideline Statement 18 Clinicians may offer tunical plication surgery to patients whose rigidity is adequate for coitus (with or without pharmacotherapy and/or vacuum device therapy) to improve penile curvature

BMC Genomics 22:302

The medication is ideal for those who have significant weight to lose (BMI 30), want a sustainable and long-term solution, and have insurance coverage or can afford the medication

So I'm going to throw in a little bit of feta here